Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/22/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Shari D. Bolen

Wrong Dr. Shari D. Bolen?

Assistant Professor of Medicine, ...

Phone: (312) ***-****  HQ Phone
Email: s***@***.edu
Local Address:  United States
Journal of the American Medical Association
AMA Plaza, 330 North Wabash, Suite 39300
Chicago , Illinois 60611
United States

Company Description: JAMA (the Journal of the American Medical Association) is an international, peer-reviewed, weekly general medical journal, and is the most widely circulated medical...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • MD
    Johns Hopkins University
  • MPH
  • M.D.
  • M.P.H.
57 Total References
Web References
Center for Health Care Research & Policy
www.chrp.org, 22 July 2015 [cached]
Shari D. Bolen, M.D., M.P.H. Assistant Professor of Medicine and Epidemiology and Biostatistics
...
Dr. Bolen conducts health services research in diabetes and obesity, with an emphasis on ways to improve care. She has a special interest in comparative effectiveness research and systematic reviews/meta-analyses.
"Our study showed that failure to ...
www.dlife.com, 10 June 2006 [cached]
"Our study showed that failure to appropriately intensify antihypertensive treatment is a very common problem in diabetes care, because physicians intensified antihypertensive treatment in only 12 percent of visits in which we found sub-optimally controlled blood pressure," said Shari Bolen, MD, Senior Clinical Fellow in Internal Medicine, The Johns Hopkins University School of Medicine, in a recent interview.
...
"Through a review of medical records and pharmacy and claims data from 1999 to 2001, we identified 1,374 visits with sub-optimally controlled blood pressure, during which physicians intensified antihypertensive treatment in only 12 percent of visits," said Dr Bolen, who was lead author on the study.
...
"Several factors were associated with a 40 to 50 percent lesser likelihood of intensification including a higher glucose level or a history of coronary heart disease, suggesting in both instances that the physician focused on other clinical concerns to the detriment of attention to the hypertension problem," said Dr. Bolen.Co-management of the individual with a cardiologist yielded a similar lesser likelihood of intensification, suggesting that the physician was perhaps erroneously relying on the cardiologist to manage the blood pressure.
"Improvements in continuity of care and care coordination are possible targets to help improve outcomes in hypertension management for people with diabetes," said Dr. Bolen.
"It looks to be the safest," ...
hamptonroads.cox.net, 16 July 2007 [cached]
"It looks to be the safest," said Dr. Shari Bolen, a Johns Hopkins University researcher who led the review, which was published online Monday by the Annals of Internal Medicine.
Consumer Reports also published a consumer guide of the results.
...
Despite heavy marketing for newer drugs, which cost as much as $262 a month, "we didn't find any benefit" unless a patient could not tolerate an older one, Bolen said.
Genetics Blog » 2011 » January
linuxq.org, 1 Jan 2011 [cached]
"Sometimes newer is not necessarily better," says lead study author Shari Bolen, M.D., an internist at Hopkins. "Issues like blood sugar levels, weight gain and cost could be significant factors to many patients struggling to stay in good health," says Bolen, an instructor at The Johns Hopkins University School of Medicine.
...
"When you are dealing with an epidemic like diabetes, it is important for people to weigh their treatment options with their physician and to make informed decisions about which medication best suits their needs," says Bolen.
In the study, Bolen and her colleagues reviewed the scientific evidence from 216 previous studies and compared each drug for its clinical effectiveness, risks and costs.
...
Besides Bolen, other researchers involved in the study were Leonard Feldman, M.D.; Jason Vassy, M.D., M.P.H.; Lisa Wilson, B.S., Sc.M.; Hsin-Chieh Yeh, Ph.D.; Spyridon Marinopoulos, M.D., M.B.A.; Crystal Wiley, M.D., M.P.H.; Elizabeth Selvin, Ph.D.; Renee Wilson, M.S.; Eric Bass, M.D., M.P.H.; and Frederick Brancati, M.D., M.H.S.
Faculty Profiles
www.metrohealthresearch.org, 15 July 2015 [cached]
Gertz, A., Blixen, C. & Frank, S. (February, 2011).
...
Stoller, E., Webster, N., Blixen, C., McCormick, R., Hund, A., Perzynski, A., Kanuch, S., Kercher., Thomas, C. , Kercher, K. & Dawson, N. (2009).
...
Blixen, C., Webster, N., Hund, A., Stoller, E., Kanuch, S., McCormick, R., & Dawson, N. (2008).
...
Shari D. Bolen, M.D., M.P.H. Assistant Professor of Medicine and Epidemiology and Biostatistics
...
Dr. Bolen conducts health services research in diabetes and obesity, with an emphasis on ways to improve care. She has a special interest in comparative effectiveness research and systematic reviews/meta-analyses.
Other People with the name "Bolen":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.